Rapid Diagnosis Of Multidrug-Resistant Tuberculosis Impacts Expenditures Prior To Appropriate Treatment: A Performance And Diagnostic Cost Analysis.
Xuezheng LiYunfeng DengJunling WangHui JingWei ShuJingmin QinYu PangXin MaPublished in: Infection and drug resistance (2019)
In conclusion, our data demonstrate that the HAIN test is an accurate rapid test for detecting both RIF and INH resistance in TB patients. The use of the HAIN test can decrease health care costs and reduce the detection time for MDR-TB patients in China, despite the increased costs for laboratory testing.
Keyphrases
- multidrug resistant
- end stage renal disease
- healthcare
- mycobacterium tuberculosis
- newly diagnosed
- ejection fraction
- emergency department
- high resolution
- loop mediated isothermal amplification
- pseudomonas aeruginosa
- big data
- human immunodeficiency virus
- machine learning
- cystic fibrosis
- mass spectrometry
- artificial intelligence
- social media
- replacement therapy
- smoking cessation
- hiv infected
- patient reported
- health insurance
- antiretroviral therapy
- quantum dots
- label free